How Long Do Semaglutide Side Effects Last?

Semaglutide side effects start most often during dose escalation, the opening 16 weeks when the dose rises in steps. The Wegovy prescribing information says gastrointestinal reactions were reported most frequently in that window. The pooled STEP analysis adds a second marker: the share of participants having a first gastrointestinal event stopped climbing after week 20.

A first stomach symptom that shows up many months into treatment deserves a mention to your prescriber, since the trials saw few first events that late.

Week one sits at the lowest dose of the schedule, and our guide to the first week on semaglutide covers how that starting step tends to feel.

Each semaglutide side effect runs on its own clock, from a median of 2 days for vomiting to 47 days for constipation in the pooled STEP trials. A median means half of the episodes ended sooner and half ran longer. Some participants had a much harder stretch than the middle figure suggests.

Diarrhea episodes lasted a median of 3 days. Participants on placebo reported similar episode lengths for nausea, diarrhea, and vomiting, which suggests the medication raised how often those symptoms happened more than how long each one went on.

How long does nausea last on semaglutide?

Nausea on semaglutide lasted a median of 8 days per episode in the pooled STEP 1 to 3 trials, similar to the length reported on placebo. Nausea was also the most common side effect, reported by 44% of participants on semaglutide 2.4 mg. Episodes were most frequent during and shortly after dose increases.

How long does constipation last on semaglutide?

Constipation on semaglutide lasted a median of 47 days per episode in the pooled STEP trials, against 35 days on placebo. Constipation is the exception to the short-episode pattern. Its frequency levelled off at about week 10, while nausea, diarrhea, and vomiting kept rising until about week 20. A stretch that long is a reason to tell your prescriber early.

Fatigue and headache have less data behind them. The Wegovy label reports fatigue in 11% of adults on semaglutide 2.4 mg and headache in 14%, and neither the label nor the pooled analysis reports how long those lasted. Any article quoting a number of days for semaglutide fatigue is quoting something we could not trace to a study.

Symptoms beyond the gut, along with the rare serious reactions, are covered in our full list of Ozempic side effects. That list applies here because Ozempic and Wegovy share semaglutide as their active ingredient.

Semaglutide side effects come back after a dose increase because the dose rises every four weeks over 16 weeks, and gastrointestinal reactions were reported most often during and shortly after those steps. The schedule exists for this reason. The prescribing information describes gradual escalation as a way to reduce gastrointestinal reactions.

Climbers heading to high altitude go up in stages on the same logic. Each new camp brings a few rough days while the body catches up, then things settle, then the next camp starts the cycle again. A climber is rarely unwell for the whole ascent. Someone watching from below, though, could count the bad days at every camp and conclude the trip was miserable from start to finish. Family members often see semaglutide that way, which is why we show them the calendar.

The pooled STEP analysis fits that picture. Nausea, diarrhea, and vomiting were most widespread at about week 20, roughly four weeks after participants reached the full dose, and declined from there. Researchers have not settled why these symptoms happen, and our post on how semaglutide works in the body walks through the leading explanations, including slowed stomach emptying early in treatment.

Pace is adjustable. The label allows a prescriber to delay the next step by four weeks when a dose is not sitting well. In the pooled trials, 12.5% of participants on semaglutide had a dose reduction or a temporary pause because of gastrointestinal symptoms. Those decisions belong to the prescriber. Changing the amount or the timing on your own carries real risk and removes the one person who can tell an expected reaction from a warning sign.

How quickly the dose rises is a decision Rick Meyers, FNP-BC, makes with each patient in our medically supervised GLP-1 program. Rick has worked with GLP-1 medications since 2015.

Semaglutide side effects declined for most trial participants once the dose stopped rising, though they did not disappear for everyone. In the pooled STEP analysis, nausea showed the steepest drop after week 20. The authors also wrote that a small proportion of patients may keep having gastrointestinal symptoms throughout treatment.

STEP 4 looked at the question directly. Researchers took 803 adults who had tolerated the first 20 weeks and either kept them on semaglutide 2.4 mg or switched them to placebo. Over the following 48 weeks, 41.9% of the group that stayed on semaglutide reported a new gastrointestinal event, against 26.1% of the placebo group. The frequency of nausea, diarrhea, and constipation in the semaglutide group fell as the weeks went on.

The STEP 4 percentages describe adults in a monitored trial with regular follow-up. They cannot predict one person's months on the medication.

Appetite and weight follow a separate timeline from side effects, which we lay out in our guide to how long semaglutide takes to work.

Semaglutide side effects that are severe, that keep going, or that show up outside the gut should not be waited out, whatever week of treatment it is. The Wegovy label carries warnings for pancreatitis, gallbladder disease, kidney injury from fluid loss, allergic reactions, and a faster resting heart rate. The label also carries a boxed warning about thyroid C-cell tumors seen in rodents.

Red flags:

• Severe stomach pain that does not ease, especially pain spreading to the back
• Vomiting or diarrhea that stops you keeping fluids down
• A lump or swelling in the neck, trouble swallowing, or lasting hoarseness
• A racing or pounding heartbeat while resting
• Swelling of the face, lips, or throat, or trouble breathing

Any item on that list means a call to your prescriber the same day. Trouble breathing or throat swelling means emergency care.

Semaglutide is prescribed after a medical evaluation and is not appropriate for everyone, including anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.